{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T01:17:44Z","timestamp":1747185464429,"version":"3.40.5"},"reference-count":72,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment\u2010related morbidity is a constant source of concern for physicians and patients alike. Positron emission tomography adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, while minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence\u2010based practice statements to simplify the management of HL.<\/jats:p>","DOI":"10.1111\/imj.15503","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T06:50:00Z","timestamp":1631256600000},"page":"2119-2128","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance"],"prefix":"10.1111","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-1399","authenticated-orcid":false,"given":"Tara","family":"Cochrane","sequence":"first","affiliation":[{"name":"Department of Haematology Gold Coast University Hospital  Gold Coast Queensland Australia"},{"name":"School of Medicine Griffiths University  Gold Coast Queensland Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7316-8723","authenticated-orcid":false,"given":"Belinda A.","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Peter MacCallum Cancer Centre  Melbourne Victoria Australia"},{"name":"Department of Clinical Pathology University of Melbourne  Parkville Victoria Australia"},{"name":"Sir Peter MacCallum Department of Oncology University of Melbourne  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane A.","family":"Gangatharan","sequence":"additional","affiliation":[{"name":"Fiona Stanley Hospital  Perth Western Australia Australia"},{"name":"University of Western Australia  Perth Western Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Latimer","sequence":"additional","affiliation":[{"name":"ACT Pathology and Canberra Hospital  Canberra Australian Capital Territory Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Khor","sequence":"additional","affiliation":[{"name":"Austin Hospital  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R. H.","family":"Christie","sequence":"additional","affiliation":[{"name":"Genesiscare  Gold Coast Queensland Australia"},{"name":"Bond University  Gold Coast Queensland Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gilbertson","sequence":"additional","affiliation":[{"name":"Monash Health  Melbourne Victoria Australia"},{"name":"School of Clinical Sciences Monash University  Melbourne Victoria Australia"},{"name":"Department of Haematology and Oncology Western Health  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumita","family":"Ratnasingam","sequence":"additional","affiliation":[{"name":"Andrew Love Cancer Centre University Hospital Geelong  Geelong Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Palfreyman","sequence":"additional","affiliation":[{"name":"Royal Darwin Hospital  Darwin Northern Territory Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui\u2010Peng","family":"Lee","sequence":"additional","affiliation":[{"name":"Flinders Medical Centre  Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-4593","authenticated-orcid":false,"given":"Judith","family":"Trotman","sequence":"additional","affiliation":[{"name":"Concord Repatriation General Hospital  Sydney New South Wales Australia"},{"name":"University of Sydney  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hertzberg","sequence":"additional","affiliation":[{"name":"Department of Haematology Prince of Wales Hospital  Sydney New South Wales Australia"},{"name":"University of NSW  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-5966","authenticated-orcid":false,"given":"Michael","family":"Dickinson","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology University of Melbourne  Melbourne Victoria Australia"},{"name":"Peter MacCallum Cancer Centre and Royal Melbourne Hospital  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017","author":"Steven Swerdlow EC","key":"e_1_2_9_2_1"},{"key":"e_1_2_9_3_1","unstructured":"Australian Institute of Health and Welfare Statistics (AIHW). Statistics ICD\u201010 C81 report. Canberra: AIHW; 2019."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2005.00467.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392104"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00964"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.6394"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408648"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510093"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111961"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.1001"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.03.019"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06598.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.9774"},{"key":"e_1_2_9_16_1","unstructured":"NSW Government. Cancer Treatments Online. Available from URL:https:\/\/www.eviq.org.au"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt413"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.015644"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064601"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000067"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5807"},{"volume-title":"Dose\u2010Intensification of Early Unfavorable Hodgkin Lymphoma: Long Term Follow Up of the German Hodgkin Study Group (GHSG) HD 14 Trial","year":"2019","author":"Gillessen S","key":"e_1_2_9_22_1"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30601-X"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211193272102"},{"key":"e_1_2_9_25_1","first-page":"CD007941","article-title":"Comparison of first\u2010line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma","author":"Skoetz N","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_53"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.6525"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12715"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32134-7"},{"volume-title":"PET Guided Treatment in Patients with Advanced Stage Hodgkin Lymphoma: Follow Up Analysis of PET\u20102 Negative Patients in the HD18 Trial by the German Hodgkin Study Group","year":"2020","author":"Kreissl S","key":"e_1_2_9_30_1"},{"key":"e_1_2_9_31_1","unstructured":"BorchmannP.HD 21 for Advanced Stages \u2013 Treatment Optimization Trial in the First\u2010Line Treatment of Advanced Stage Hodkin Lymphoma: Comparison of 4\u20106 cycles of escalated BEACOPP with 4\u20106 cycles of BrECADD.2017 Version 5.0."},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30784-8"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708984"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.7532"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61940-5"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00935"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15652"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-378414"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.4181"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-681064"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61469-0"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-368167"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190601126610"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24178"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.09.048"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.07.131"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1667\/RR2240.1"},{"key":"e_1_2_9_48_1","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Hodgkin Lymphoma (Version 4.2021). NCCN; 2021 [updated 2021 Apr 20; cited 2021 19 Jul]. Available from URL:https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hodgkins.pdf"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505949"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.323"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj017"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.8835"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.07.016"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-579193"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.11.046"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.9174"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31807"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.05.021"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.10.004"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-512657"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0048"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1369063"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.06.013"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.135"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw211"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.946901"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1667\/RR14888.1"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.02.009"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.3721"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00562"},{"key":"e_1_2_9_71_1","unstructured":"International Guideline Harmonization Group (IGHG) for Late Effects of Childhood Cancer.IGHG;2019. Available from URL:http:\/\/www.ighg.org\/"},{"key":"e_1_2_9_72_1","unstructured":"Children's Oncology Group. Long\u2010Term Follow\u2010up Guidelines for Survivors of Childhood Adolescent and Young Adult Cancers Version 5.0. Children's Oncology Group; 2018 [updated 2018 Oct; cited 2019 Dec 29]. Available from URL:http:\/\/www.survivorshipguidelines.org\/pdf\/2018\/COG_LTFU_Guidelines_v5.pdf"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70409-7"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.15503","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.15503","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.15503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T07:00:31Z","timestamp":1693206031000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.15503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1111\/imj.15503"],"URL":"https:\/\/doi.org\/10.1111\/imj.15503","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"type":"print","value":"1444-0903"},{"type":"electronic","value":"1445-5994"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"assertion":[{"value":"2021-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}